Clinical trial
Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00002933 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002933 |
|---|---|
| Title | Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer |
| Official title | CWRU 1296: Biochemical and Pharmacokinetic Predictors of Colon Cancer Response to a Topoisomerase I Directed Treatment With Irinotecan |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride |
| Enrollment | 21 |
| Start date | Sep 1, 1996 |
| Primary completion | Jul 1, 2000 |
| Completion | Jan 1, 2001 |
| First posted | Aug 12, 2004 |
| Last update posted | Jul 27, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: